Robotic Precision
Automated liquid handling ensures reliable, reproducible dispensing across 96/384 wells, minimizing human error and variability.
The High-Throughput Cell-Free Protein Expression (HT-CFPS) Service leverages the speed, flexibility, and open nature of Cell-Free Protein Synthesis (CFPS) to accelerate protein discovery. This platform utilizes automated liquid handling systems and miniaturized reaction formats (96- or 384-well plates) to synthesize hundreds to thousands of target proteins simultaneously. By eliminating the time and variability associated with live cell culture, HT-CFPS drastically reduces project timelines for large-scale screening and prototyping, making it a critical tool for synthetic biology, directed evolution, and early-stage drug target validation .
CD Biosynsis offers highly flexible HT-CFPS solutions, compatible with various lysates including E. coli, WGE, and RRL, allowing clients to select the optimal system based on their protein's complexity and PTM requirements. Our automated pipeline ensures unparalleled precision, reproducibility, and rapid iteration , enabling the synthesis of diverse protein libraries, optimization of expression conditions, and direct functional screening of unpurified protein products.
Get a QuoteCore benefits of our HT-CFPS platform:
Key areas benefiting from high-throughput cell-free protein expression:
Directed Evolution & Enzyme Screening
Rapid synthesis and functional testing of large mutant enzyme libraries to identify variants with enhanced activity or stability.
Synthetic Biology Prototyping
Fast testing of genetic circuits, co-expression of multi-enzyme pathways, and optimization of stoichiometry in vitro .
Drug Target & Antibody Library Screening
Synthesis of multiple protein targets (e.g., scFvs, kinases) for immediate use in binding, functional, or activity assays.
Structural Biology Labeling (NMR)
Cost-effective, high-throughput incorporation of stable isotopes (15N, 13C) for structural analysis of protein libraries.
The comparative advantage of our automated HT-CFPS:
Robotic Precision
Automated liquid handling ensures reliable, reproducible dispensing across 96/384 wells, minimizing human error and variability.
Template Flexibility
Compatible with linear DNA (PCR product), plasmid DNA, or mRNA, enabling direct screening from gene synthesis or PCR amplification.
Lysate Agnosticism
We can implement E. coli (high yield), WGE (low background), or RRL (eukaryotic fidelity) based on the project's specific needs.
Assay Integration
Synthesis is often performed directly in assay-compatible microplates, allowing for immediate functional analysis without intermediate purification.
Custom Additives Screening
High-throughput testing of hundreds of different additives (e.g., detergents, lipids, cofactors, chaperones) for optimized folding.
Our streamlined process for high-speed, parallel protein expression:
We provide essential assurance for high-quality HT-CFPS outcomes:
Which lysate system is best for HT-CFPS?
The optimal system depends on the application. E. coli is typically used for highest yield and simple proteins. WGE is preferred for NMR labeling and low-background assays. RRL or HEK293 are used when accurate eukaryotic PTMs are essential.
What kind of libraries can be screened using HT-CFPS?
We can screen point mutation libraries, random codon mutagenesis libraries, domain shuffling libraries, and sequence libraries for antibodies (scFv, Fab fragments), receptors, and enzymes.
Does the protein need to be purified before screening?
No. One of the main advantages of HT-CFPS is the ability to screen proteins directly from the crude lysate reaction, saving time. If purification is required, we can perform automated small-scale purification steps.
What is the typical reaction volume?
Standard volumes range from 10 microliters to 50 microliters per well in 96- or 384-well plates, minimizing the cost of custom amino acids and isotopic labels.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.